Detalhe da pesquisa
1.
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Blood
; 2024 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754055
2.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38705160
3.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
N Engl J Med
; 386(26): 2482-2494, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657079
4.
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.
Blood
; 139(12): 1863-1877, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932792
5.
High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis.
Blood
; 139(10): 1557-1563, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662377
6.
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 - a Nordic Lymphoma Group study.
Haematologica
; 109(4): 1171-1183, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646663
7.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Br J Haematol
; 202(4): 749-759, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257914
8.
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors.
Haematologica
; 108(4): 1092-1104, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519324
9.
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group.
Am J Hematol
; 98(3): 388-397, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588403
10.
Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission.
Br J Cancer
; 127(9): 1642-1649, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999271
11.
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients.
Br J Haematol
; 198(2): 267-277, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468219
12.
Advances in immune therapies in hematological malignancies.
J Intern Med
; 292(2): 205-220, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624160
13.
Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience.
Hematol Oncol
; 40(1): 22-30, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713465
14.
Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis.
Int J Cancer
; 148(9): 2115-2128, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33128820
15.
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors.
Br J Haematol
; 193(3): 520-531, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686666
16.
Detecting deviations from the efficacy and safety results of single-arm trials using real-world data: The case of a CAR-T cell therapy in B-cell lymphoma.
Pharmacoepidemiol Drug Saf
; 30(4): 514-519, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33432654
17.
Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study.
Int J Cancer
; 147(6): 1649-1656, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32176325
18.
Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study.
Br J Haematol
; 189(1): 106-116, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721156
19.
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study.
Br J Haematol
; 189(6): 1083-1092, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32065396
20.
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma.
Br J Haematol
; 191(5): 796-805, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748433